Durability and Patient Experience Outcomes Across Major BPH Treatments
Recovery
Rapid symptom relief and recovery1,3
Lowest Catheter Rate
Compared to leading BPH procedures2-7
Safe
Lowest rate of complications at one year*20
Durable
Low surgical retreatment rate2
Consistent, Durable Outcomes
Five-year data across UroLift™ System studies demonstrate that outcomes are rapid, durable and reproducible.1,2,10
Symptom Response Is Largely Consistent Among Controlled Subjects and Real-World Retrospective Cohorts
Sustained IPSS Improvement
Improvement in LUTS, as seen through average reduction in IPSS, has been largly consistent across various studies, showing rapid relief within two weeks and sustained effect through five years.1,2 Symptom relief is better than reported for medications.1,11
Quality of Life Improvement
Significant increase in quality of life scores with 51% improvement observed at 1 year and was sustained at 50% in a 5 year study, p<0.0001.2
Flow Rate Improvement
In addition to improving LUTS, the UroLift™ System treatment has demonstrated significant improvement in peak urinary flow rate (Qmax) of 3.5 mL/sec (44%) that was sustained to five years, p<0.0001.2
Low Retreatment Rate
The rate of surgical intervention for failure to cure with the UroLift™ System was low for a BPH procedure, with approximately 13.6% over the five year study.1,2
FDA Guidance on Clinical Investigation of Devices for BPH
“Because loss to follow-up jeopardizes the conclusions that can be made about the long-term safety and effectiveness of a device, we recommend you limit the overall rate of loss to follow-up to less than 20% over the course of the study.” 17,§
§ Rezum and Aquablation are FDA-cleared devices
Extensive Clinical Evidence Support the UroLift™ System
For 10+ years, supported by over 145 peer-reviewed and 22 sponsored publications, the UroLift™ System has been proven to provide generally consistent outcomes between randomized clinical trials and the real world, in a large variety of prostate types, including those with obstructive median lobe and large prostates up to 100cc.18,19
“The UroLift™ System is the most well-studied minimally invasive surgical therapy for BPH. In a combined analysis from five controlled studies, we found that the majority of men who had received the procedure demonstrated measurable improvement in their BPH symptoms, flow rate, and quality of life. Subjects preserved their sexual function while some patients even experienced improvement in IIEF and MSHQ-EjD scores."
